Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
This observational study (n=343) of terrorist attack survivors found that those under the influence of classic psychedelics during the traumatic event reported lower anxiety and post-traumatic symptoms compared to MDMA users or non-users, particularly when psychedelics were taken alone.
Authors
- Karp Barnir, E.
- Rubinstein, Z.
- Abend, R.
Published
Abstract
Emerging evidence indicates the therapeutic potential of psychedelic compounds for post-traumatic stress, yet the mechanisms mediating their effects remain unclear. Delineating the effect of psychedelics on traumatic memory formation could shed light on target therapeutic mechanisms. Here, we report on 343 adult survivors of a single, large-scale terrorist attack taking place during a festival in which different psychedelic compounds were consumed, in whom levels of anxiety and post-traumatic symptoms were assessed 3 weeks following the attack. Findings indicated that those who were under the influence of classic psychedelics during the attack reported significantly lower levels of anxiety and post-traumatic responses compared to those who were under the influence of 3,4-methylenedioxymethamphetamine and those who consumed no psychedelics. Furthermore, the protective effects of classic psychedelics for post-traumatic responses manifested more strongly among participants who did not consume additional recreational substances alongside psychedelics. These findings suggest that pharmacologic targets of classic psychedelics may modulate the formation of enduring trauma memories and confer a protective effect against the development of post-traumatic stress and anxiety responses.
Research Summary of 'Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure'
Introduction
Earlier research has highlighted potential therapeutic effects of psychedelic compounds for post-traumatic stress, but the neurobiological mechanisms that might mediate these effects remain unclear. Classic psychedelics (for example LSD and psilocybin) and MDMA engage overlapping but distinct neurotransmitter and receptor systems, and experimental work suggests they may differently affect the encoding and consolidation of fear memories. Extending these laboratory and animal findings to real-life trauma exposure is an important gap in the literature. Karp Barnir and colleagues used a naturalistic opportunity to compare outcomes following peri-traumatic use of different recreational psychedelics. They assessed survivors of a mass terrorist attack at a music festival who, in the hours before the assault, had consumed either classic psychedelics, MDMA, or no psychedelics, and measured anxiety and acute post-traumatic symptoms three weeks after the event to test whether peri-traumatic compound type was associated with differences in early trauma responses. The authors frame this as informative for understanding mechanisms that could influence eventual PTSD trajectories and for identifying pharmacologic targets relevant to trauma memory formation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Topics
- APA Citation
(2025). Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure. Journal of Psychopharmacology. https://doi.org/10.1177/026988112513340
References (9)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Doss, M. K., Samaha, J., Barrett, F. S. et al. · Biorxiv (2022)
Doss, M. K., Weafer, J. J., Gallo, D. A. et al. · Neuropsychopharmacology (2017)
Halman, A., Kong, G., Sarris, J. et al. · Journal of Psychopharmacology (2023)
Hinkle, J. T., Graziosi, M., Nayak, S. et al. · JAMA Psychiatry (2024)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Kopra, E., Cleare, A. J., Rucker, J. et al. · Journal of Affective Disorders (2022)
Netzer, O., Magal, N., Stern, Y. et al. · Biorxiv (2024)
Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)
Cited By (1)
Papers in Blossom that reference this study
Evens, R., Uyar, A., Gosslau, E. et al. · Psychological Medicine (2026)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.